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Ferritin is a multisubunit protein that is responsible
for storing and detoxifying cytosolic iron. Ferritin
can be found in serum but is relatively iron poor.
Serum ferritin occurs in iron overload disorders, in
inflammation, and in the genetic disorder hyperferri-
tinemia with cataracts. We show that ferritin secre-
tion results when cellular ferritin synthesis occurs in
the relative absence of free cytosolic iron. In yeast
and mammalian cells, newly synthesized ferritin
monomers can be translocated into the endoplasmic
reticulum and transits through the secretory appa-
ratus. Ferritin chains can be translocated into the
endoplasmic reticulum in an in vitro translation and
membrane insertion system. The insertion of ferritin
monomers into the ER occurs under low-free-iron
conditions, as iron will induce the assembly of
ferritin. Secretion of ferritin chains provides amecha-
nism that limits ferritin nanocage assembly and
ferritin-mediated iron sequestration in the absence
of the translational inhibition of ferritin synthesis.
INTRODUCTION
Ferritin is the major iron storage molecule of vertebrates. The
mature protein complex, referred to as a nanocage, contains
24 subunits of a mixture of L- and H-ferritin monomers. Ferritin
is capable of storing up to 4500 atoms of iron (Theil, 2004).
Ferritin synthesis is regulated transcriptionally by a variety of
inflammatory cytokines and posttranscriptionally by cytosolic
iron (Rouault, 2006). In the absence of iron, cytosolic iron regula-
tory protein (IRP)-1 and/or IRP-2 binds to a stem-loop structure
in the 50 untranslated region of ferritin mRNA termed the iron-
responsive element (IRE), preventing translation. Increased
cytosolic iron releases the IRP from the IRE, permitting transla-
tion of ferritin mRNA and subsequent iron storage in the ferritin
nanocage.
Ferritin can also be found in the serum of vertebrates. There
are three notable conditions that result in high levels of serum
ferritin: genetic and transfusion iron-overload diseases, inflam-
mation (Rambod et al., 2008), and the rare human genetic
disorder hyperferritinemia with cataracts (Hetet et al., 2003).
This disorder is due to mutations in the 50 IRE of either L- or
ET
RCH-ferritin, which prevents binding of the IRP to the IRE, resulting
in the uncoupling of ferritin synthesis from iron-mediated control.
Serum ferritin is frequently used in clinical settings, but the
mechanism of secretion as well as the function of serum ferritin
is unclear. In contrast to cytosolic ferritin, serum ferritin is
relatively iron poor and has only a fraction of the iron content
of cytosolic ferritin. For example, serum ferritin found in highly
iron-overloaded individuals may have as little as 2.0% of the
iron content of cytosolic ferritin (ten Kate et al., 2001). Ferritin
does not have a canonical signal sequence, and the mechanism
of its release from cells remains unclear. Except for the terminal
stages of liver disease, the presence of serum ferritin cannot be
ascribed to cell damage, as the usual indicators of cell death
such as cytosolic enzymes are not present in serumwhen serum
ferritin levels are high (Worwood, 1979). Secreted human ferritin
was reported to contain N-linked sugars as well as bind to
concanavalin A, another indicator of carbohydrate content
(Cragg et al., 1981), although the extent of glycosylation is highly
variable and has not been seen consistently. Secretion of ferritin
by cultured hepatocytes has been reported to be the product of
a unique mRNA (Tran et al., 1997) and has been reported for
hepatocytes grown in the absence of serum (Ghosh et al.,
2004) or in canine lens cells transfected with plasmids express-
ing H- or L-ferritin, although the mechanism of secretion was not
determined (Chen et al., 2005; Coffman et al., 2009; Goralska
et al., 2003). A recent study suggested that serum ferritin was
primarily derived from the release of ferritin from macrophage
lysosomes (Cohen et al., 2010). Here, we demonstrate that
secretion of ferritin results from insertion of ferritin monomers
into the secretory apparatus and that many cell types are
capable of secreting ferritin. Secretion of ferritin results from
ferritin synthesis in the relative absence of free cytosolic iron,
and ferritin nanocage assembly is iron dependent. We suggest
that secretion of ferritin protects cells from excessive depletion
of free cytosolic iron when ferritin chain synthesis is uncoupled
from IRP regulation.
RESULTS
Ferritin Chain Secretion Results from Increased
Cytosolic Iron
Increased serum ferritin is seen in iron overload disorders where
iron can be found in hepatocytes or macrophages, depending on
the nature of the mutant gene. Mutations in the iron exporter
ferroportin (Fpn) are the cause of Type IV hemochromatosis
(Pietrangelo, 2004). Defective cellular iron export leads to high
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Figure 1. Ferritin Is Secreted by Mouse Bone Marrow Macrophages
(A) ffe/+ mouse bone marrow macrophages were incubated with or without iron (FAC, 10 mM Fe) for 24 hr followed by incubation without iron for an additional
18 hr (+/). Media and cells were harvested and ferritin content determined by ELISA. The data are expressed as ng ferritin per culture.
(B) Wild-type (C3H) mouse bone marrow macrophages were incubated with iron (FAC, 10 mM Fe) for 24 hr. After iron was removed (+/), cells were incubated in
presence or absence of hepcidin (1 mg/ml media) for 4 hr. Ferritin levels were analyzed as in (A).
(C) Wild-type (C3H) macrophages were incubated with iron (FAC, 10 mM Fe). After 24 hr, media were collected and cells were lysed. Ferritin levels were detected
by western blot using a rabbit anti-L-ferritin antibody or a rabbit anti-H-ferritin antibody followed by a peroxidase-conjugated goat anti-rabbit IgG.
(D) Serumwas obtained fromWT (C3H), ffe/+, and HAMP/mice. Ferritin levels weremeasured as described in (C). Error bars represent the standard error of the
mean of three independent experiments.
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Dcytosolic iron, high cytosolic ferritin, and high levels of serum
ferritin. The flatiron (ffe/+) mouse is a model of this disorder, as
these mice are heterozygous for a missense mutation in the
iron exporter Fpn (Zohn et al., 2007). Cellular ferritin levels
increased in cultured ffe/+ macrophages incubated with iron-
containing medium. Ferritin levels remained high when iron-con-
taining medium was removed, because the cells expressing the
mutant Fpn cannot export iron (Figure 1A). The amount of
medium ferritin increased over time and at 24 hr was equivalent
to 1.5 times the cellular content of ferritin. We performed similar
experiments with wild-type macrophages. Incubation of wild-
type macrophages with iron led to an increase in cellular ferritin,
which decreased when iron was removed (Figure 1B). Ferritin
was also found in the medium during the incubation with iron
and after iron had been removed. Hepcidin, encoded by the
HAMP gene, prevents cellular iron export by inducing the inter-
nalization and degradation of Fpn (Nemeth et al., 2004). In the
presence of hepcidin, both cytosolic and medium ferritin
increased to the levels seen in iron-exposed ffe/+macrophages.
Similar results were obtained in Hepa cells (mouse liver hepa-
toma) and HEK293T (human embryonic kidney) cells; incubation
of cells with iron led to increased cellular iron and increased
medium ferritin (data not shown). The accumulation of ferritin in
the medium in all cell types was not accompanied by significant
levels of cytosolic proteins (LDH) or lysosomal proteins (b-hexos-
aminidase) (data not shown). A recent study has shown that
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the medium (Cohen et al., 2010). We confirmed this result, but
observed that iron-loaded macrophages will release ferritin
and hexosaminidase when given a change in medium (Fig-
ure S1A). The data suggest that the change in medium can
lead to fusion of lysosomes with the cell surface, resulting in
the loss of lysosomal contents. In contrast, cells exposed contin-
uously to iron without a medium change did not release lyso-
somal content but did secrete ferritin (Figure S1B).
Ferritin secreted by cultured macrophages showed the same
electrophoretic mobility as cytosolic ferritin (Figure 1C). The
electrophoretic mobility of ferritin in the serum of ffe/+ and
HAMP/mice was similar (Figure 1D). HAMP/mice accumu-
late iron in hepatocytes rather than in macrophages, as seen in
ffe/+ mice. There is a difference in the ratio of H- and L-ferritin
between the two strains of mice, which is consistent with the
finding that the ratio of H- and L-ferritin is cell-type specific.
These results indicate that ferritin released into the medium of
cultured cells is similar in size to ferritin found in mouse serum.
Thus, iron accumulation in macrophages or hepatocytes leads
to the secretion of ferritin.
Secretion of Ferritin Occurs through the Classical
Secretory Apparatus
The finding that (mouse) serum ferritin has the same electropho-
retic mobility as cytosolic ferritin suggests that it is not
Figure 2. Newly Synthesized Ferritin Is
Secreted by the Classic Secretory Appa-
ratus
(A) Wild-type (C3H) mouse bone marrow macro-
phages were incubated with iron (FAC, 10 mM
Fe) for 18 hr followed by incubation in the presence
or absence of cycloheximide (75 mg/ml media) for
6 hr. Ferritin levels were analyzed using an ELISA.
The data are expressed as ng ferritin per culture.
(B) Wild-type (C3H) mouse bone marrow macro-
phages were incubated with iron for 24 hr followed
by incubation in the presence or absence of BFA
(5 mg/ml media) for 2 or 4 hr. Media and cells
were harvested and ferritin content determined
by ELISA.
(C) Wild-type (C3H) mouse bone marrow macro-
phages were transfected with either control oligo-
nucleotides (NS, nonspecific) or oligonucleotides
specific for mouse Mon1a and incubated 24 hr
followed by incubation with iron (FAC, 10 mM Fe).
After 24 hr, iron was removed (+/), cells were
incubated for 18 hr, and media and cells were har-
vested. Ferritin levels were measured by ELISA.
The efficiency of Mon1a depletion was assessed
by western blot analysis using antibodies to
Mon1a and tubulin. Error bars represent the
standard error of the mean of three independent
experiments.
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effect on the mass of ferritin from serum or cytosol (data not
shown). One interpretation of this result is that ferritin is not
secreted through the classic secretory apparatus. Iron-loaded
macrophages treated with the protein synthesis inhibitor cyclo-
heximide did not secrete ferritin, suggesting that newly synthe-
sized ferritin chains are being secreted (Figure 2A). We utilized
pulse-chase experiments to confirm this result. Iron-exposed
macrophages were incubated with 35S-methionine for 30 min,
washed, and incubated in medium containing high levels of
nonradioactive methionine. At selected times, cell extracts and
medium were collected. The appearance of radioactive ferritin
in medium showed a lag compared to incorporation of radioac-
tivity into cellular ferritin (Figure S2A). Addition of Brefeldin A
(BFA) to cells, which induces the collapse of the Golgi into the
ER, prevented the secretion of ferritin (Figure 2B). Previously,
we demonstrated that reduction in Mon1a affects movement of
proteins through the secretory pathway (Wang et al., 2007).
Reducing Mon1a levels using RNAi in iron-loaded cells
decreased the amount of medium ferritin (Figure 2C). We note
that the levels of cytosolic ferritin did not increase as expected
in Mon1a-silenced cells. We ascribe the lack of increase to the
fact that cytosolic ferritin can be degraded by autophagy or
through the proteasome (De Domenico et al., 2009).
If medium ferritin is being secreted, then we expect to find it
within membrane-bounded compartments in the cytosol. To
examine that possibility, Mon1a-silenced cells were incubated
with iron to induce ferritin synthesis, and the cells were homog-
enized. A postnuclear supernatant was applied to the bottom of
a Percoll gradient, the gradient was centrifuged, andmembrane-
containing buoyant fractions were assayed for ferritin using an
ELISA. Addition of Triton X-100 did not affect the measured level
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contain cytosolic ferritin (Figure S2B). Ferritin was detected in
a buoyant fraction, but only when Triton X-100 was added,
reflecting membrane association. This result demonstrates that
ferritin was membrane enveloped, preventing the access of
anti-ferritin antibodies.
The Saccharomyces cerevisiae genome does not contain
ferritin genes, but mammalian ferritin can be expressed in yeast,
and the assembled nanocage can accumulate iron (Kim et al.,
2003; Shi et al., 2008). We utilized yeast with a ts allele in the
SEC61 gene (sec61-2), which encodes a subunit of the ER
translocation channel (Stirling et al., 1992). Wild-type and
sec61-2 strains were transformed with a plasmid expressing
human H-ferritin, lacking the 50 IRE, under the control of the
GAL1 promoter. In the absence of galactose, ferritin was not
synthesized in either yeast strain (data not shown). In the pres-
ence of galactose, all strains synthesized ferritin and secreted
a significant amount of ferritin at the permissive temperature
(Figure 3). At the restrictive temperature, the ratio of secreted
to cellular ferritin was unchanged in the wild-type strain. In the
sec61-2 strain, ferritin secretion was reduced at the restrictive
temperature while cell-associated ferritin increased. We
confirmed this result using another ts yeast mutant sec18-1.
SEC18 encodes NSF-1, an ATPase required for vesicle traf-
ficking (Burd et al., 1997). In the sec18-1 strain, ferritin secretion
was reduced at the restrictive temperature, similar to sec61-2
(data not shown). These results demonstrate that ferritin secre-
tion occurs by the conventional secretory pathway requiring
ferritin entry into the ER and then vesicular traffic through
the secretory apparatus. We note that in contrast to mammalian
cells, inhibition of ferritin secretion resulted in a correspond-
ing increase in cytosolic ferritin. These results suggest that
Aell Metabolism 13, 57–67, January 5, 2011 ª2011 Elsevier Inc. 59
Figure 3. Ferritin Expressed in Yeast Is Secreted in the Media
(A and B) Wild-type (WT) (A) and sec61-2 (B) strains were transformed with
a pGAL-H-ferritin plasmid. Cells were grown in medium with or without galac-
tose for 20 hr at either 22C or 37C. Media were collected, cells were
harvested, and ferritin levels were determined by ELISA. Error bars represent
the standard error of the mean of three independent experiments.
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degradation of cytosolic ferritin is different between yeast and
mammalian cells.
Insertion of Ferritin Chains into the ER In Vitro
Since yeast do not have ferritin genes, the fact that they can
secrete ferritin indicates that no special mammalian apparatus
is necessary for ferritin secretion and that the information for
secretion is intrinsic to the ferritin sequence. This conclusion
was confirmed by demonstrating that ferritin could be inserted
into the ER in an in vitro translation and insertion system.
mRNA extracted from mouse bone marrow macrophages was
added to a reticulocyte lysate containing 35S-methionine, and
synthesized ferritin was immunoprecipitated and analyzed by
SDS-PAGE. Ferritin synthesized in the presence or absence of
iron was susceptible to Proteinase K (PK) digestion (Figure 4A).
The addition of canine pancreatic microsomes to the in vitro
translation system did not affect ferritin synthesis or the ability
of PK to digest ferritin made in the presence of iron. In the
absence of iron, however, PK-mediated ferritin digestion was
only observed in the presence of Triton X-100. Lack of insertion
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copper (Figure S3), manganese, and zinc did not promote PK
resistance (data not shown).
Macrophages synthesize ceruloplasmin (Cp), which is found
as either a secreted protein or as a cell-surface GPI-linked
protein. Macrophage mRNA added to the reticulocyte lysate
resulted in the synthesis of Cp, which became PK resistant in
the absence of Triton X-100 regardless of whether iron was
added (Figure 4B). Newly synthesized Cp migrated at a higher
than predicted molecular weight, suggesting that the protein
was glycosylated within microsomes. Addition of endoglycosi-
dase H resulted in a decrease in molecular weight, suggesting
that the protein was N-glycosylated, confirming the efficacy of
the PK assay.
To determine if ferritin can be inserted posttranslationally, we
utilized an in vitro system in which L-ferritin mRNA was tran-
scribed in vitro and then added to the in vitro translation/insertion
system in the presence or absence of iron. Translation was
allowed to occur for 30 min, and then cycloheximide was added
to inhibit further translation. Canine pancreatic microsomeswere
added, and insertion into the ER was assayed after 30 min by PK
sensitivity. In the absence of iron, ferritin chains were inserted
into the ER, as shown by the requirement of Triton X-100 for
PK digestion (Figure 4C). This result indicates ferritin chains
may be inserted into the ER posttranslationally and brings up
the question of whether ferritin chains were inserted as mono-
mers or were assembled into a nanocage prior to insertion.
Most newly synthesized ferritin translated in the presence
of iron assembled into high-molecular-weight structures, as
analyzed by size-exclusion chromatography (Figure 5A). In the
absence of iron, ferritin inserted into microsomes appeared
primarily asmonomers or possibly dimers. These results suggest
that iron is required for ferritin assembly. In the absence of iron
and microsomes, synthesized ferritin remained monomeric, but
in the presence of iron the amount of monomeric ferritin was
reduced, with a commensurate increase in multimeric ferritin
(Figure 5B). Newly synthesized ferritin remained monomeric in
the presence of 5 mM iron but assembled into nanocages at
10 mM iron and higher (Figure 5C). These results show that iron
is required for the assembly of the ferritin nanocage.
The Amino Terminus of Ferritin Chains Contains ER
Targeting Information
To identify the structural determinates on ferritin necessary for its
entry into the ER, we developed a series of amino- and carboxy-
terminal FLAG-tagged L-ferritin constructs. In vitro transcribed
mRNA was added to the in vitro translation system in the pres-
ence or absence of canine microsomes. Both amino- and car-
boxy-terminal FLAG-ferritin chains were synthesized and were
susceptible to PK digestion in the absence of microsomes
(Figures 6A and 6B). The crystal structure of ferritin indicates
that the carboxyl tail of ferritin is located within the assembled
nanocage (Clegg et al., 1980; Ford et al., 1984). This finding
suggests that a carboxyl epitope tag will be in the cavity of ferritin
and thus not seen by FLAG antibodies. Studies, however,
suggest that ferritin carboxyl tags do not necessarily affect
ferritin nanocage formation or ferritin function (Millholland et al.,
2003; Missirlis et al., 2007) and that carboxyl epitopes can be
found on the outside surface of the nanocage (Luzzago and
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Figure 4. Iron Depletion Induces Ferritin Secretion
(A) mRNA extraction fromwild-typemouse bonemarrowmacrophageswas performed as described in the Experimental Procedures. ThemRNAwas used in vitro
to synthesize ferritin in the presence of a reticulocyte lysate containing 35S-methionine and in the presence or absence of canine pancreatic microsomal
membranes. The in vitro translation was performed in the presence or absence of iron (FAC, 10 mM Fe). In vitro translates were treated with or without PK in
the presence or absence of 1% Triton X-100, and the synthesized ferritin was immunoprecipitated using mouse anti-ferritin (Sigma). Immunoprecipitates
were analyzed by SDS-PAGE followed by autoradiography.
(B) mRNA from wild-type mouse bone marrow macrophages was treated as in (A) and Cp immunoprecipitated; the immunoprecipitates were treated with or
without Endo H. Immunoprecipitates were separated on SDS-PAGE, followed by autoradiography.
(C) L-ferritin mRNA was transcribed in vitro as described in the Experimental Procedures, and in vitro translation was performed as in (A) in the presence or
absence of iron (FAC, 10 mM Fe) for 30 min. Cycloheximide was added to inhibit further translation, and canine pancreatic microsomes were added. The synthe-
sized ferritin was treated as in (A), and immunoprecipitated ferritin was detected by autography.
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carboxyl FLAG epitope was recognized by anti-FLAG antibody
by immunoprecipitating ferritin translated in vitro in the presence
of iron and then assaying whether ferritin was depleted from the
extract using a ferritin ELISA. Carboxy-terminal FLAG epitope
ferritin can be completely removed by anti-FLAG antibodies,
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showing that the FLAG epitope is accessible to the antibody
(Figure S4).
Addition of microsomes resulted in the posttranslational
insertion of carboxy-terminal FLAG-tagged ferritin but not
amino-terminal FLAG-tagged ferritin, suggesting that the amino
terminus of ferritin is required for membrane insertion. WeFigure 5. Iron Induces the Formation of
Ferritin Nanocage
(A) Cytosolic ferritin and membrane-associated
ferritin synthesized in vitro in the presence or
absence of iron were applied to a Superdex 200
FPLC column in the presence of 1.0% Triton
X-100. Fractions were collected and examined
for ferritin by western blot analysis.
(B) Ferritin synthesized in the absence of
membranes in vitro was incubated with or without
iron (FAC, 10 mM Fe), and ferritin assembly was
analyzed as in (A) using fractions 5 and 75.
(C) In vitro synthesized ferritin as in (B) was incu-
bated with different amounts of iron (FAC, 5, 10,
and 30 mMFe), and ferritin assembly was analyzed
as in (A) using fractions 5 and 75.
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Figure 6. The Amino Terminus of Ferritin Is Required for Secretion
(A) L-ferritin mRNA containing the coding sequence for a FLAG tag at the amino terminus was transcribed in vitro as described in the Experimental Procedures.
The mRNA was used in vitro to synthesize ferritin in presence of a reticulocyte lysate containing 35S-methionine and iron (FAC, 10 mM Fe) and in the presence or
absence of canine pancreatic microsomal membranes. The in vitro translation was performed in the presence or absence of iron (FAC, 10 mM Fe). In vitro trans-
lates were treatedwith or without PK in the presence or absence of 1%Triton X-100, and the synthesized ferritin was immunoprecipitated usingmouse anti-FLAG
(Sigma). Immunoprecipitates were analyzed by SDS-PAGE followed by autoradiography.
(B) L-ferritin mRNA containing the coding sequence for a FLAG tag at the C terminus was transcribed and translated in vitro and analyzed as in (A).
(C) HEK293T cells were transfected with empty plasmid (pCMV), plasmid containing L-ferritin (pCMV-Ft), plasmid containing L-ferritin with an amino-terminal
FLAG tag (pCMV-FLAG-Ft), L-ferritin with a carboxy-terminal FLAG tag (pCMV-Ft-FLAG), or mutant T30I L-ferritin (pCMV-Ft-T30I). Twenty-four hours after trans-
fection, media were collected and cells harvested. Ferritin levels were measured by ELISA.
(D) Mutant T30I L-ferritin mRNA was transcribed and translated in vitro as in (A), and ferritin was analyzed by SDS-PAGE and autoradiography.
(E) Full-length L-ferritin-GFP, L-ferritin (WT-GFP), mutants 15 aa + GFP (truncated mutant expressing the first 15 aa of L-ferritin), and 25 aa + GFP (truncated
mutant expressing the first 25 aa of L-ferritin) were transfected in HEK293T cells. After 24 hr, ferritin localization was assayed by epifluorescence microscopy,
media and cells were harvested, and ferritin content was analyzed by western blot using rabbit anti-GFP followed by peroxidase-conjugated goat anti-rabbit IgG
and ELISA. Error bars represent the standard error of the mean of three independent experiments.
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ferritin in cultured cells. Transfection of cells with the CMV-driven
L-ferritin construct resulted in increased cytosolic ferritin and
secreted ferritin (Figure 6C). Expression of FLAG-L-ferritin
resulted in accumulation of ferritin in cells with little ferritin in
the medium. In contrast, L-ferritin-FLAG expressed in cells was
present in both the cytosol and medium. The presence of the
carboxy-terminal epitope affected the accumulation of cytosolic
ferritin, perhaps reflecting a higher rate of degradation.
Kannengiesser et al. identified a pedigree in which a Thr30Ile
(T30I) missense mutation in the coding sequence of human
L-ferritin resulted in high levels of serum ferritin (Kannengiesser
et al., 2009). We transformed cells with a CMV plasmid contain-
ing human L-ferritin containing the T30I mutation. Transfected
cells showed high levels of secreted ferritin compared to wild-
type ferritin (Figure 6C). We then examined the effect of this
RE62 Cell Metabolism 13, 57–67, January 5, 2011 ª2011 Elsevier Inc.mutation on ferritin secretion in vitro. mRNA for wild-type or
the T30I human L-ferritin was transcribed in vitro and added to
the reticulocyte translation system in the presence of canine
microsomes. In the presence of iron, normal L-ferritin was not
inserted into microsomes while L-ferritin T30I was inserted
(Figures 6B and 6D).
To further define the ferritin sequence sufficient for insertion
into the ER and secretion, we made fusion constructs between
the first 15–25 amino acids (aa) of L-ferritin and GFP and
measured secretion of the chimeric GFP in medium. Full-length
L-ferritin-GFP was found in the cytosol and in the medium in
cells maintained in ambient iron medium (Figure 6E). (We note
that L-ferritin-GFP in the medium was found as protein aggre-
gates, indicating that the presence of C-terminal GFP affects
protein solubility.) Expression of 1-25aa-L-ferritin-GFP led to
a protein that accumulated to higher levels in the cytosol than
Figure 7. Cytosolic Iron Chelation Enhances Ferritin Secretion
(A) Wild-type (C57BL/6) mouse fibroblasts were incubated with iron (FAC, 10 mM Fe). After 24 hr, media were collected and cells were incubated with new media
containing iron with or without 100 mM desferasirox for 2 hr. Ferritin levels in cells and media were analyzed using an ELISA.
(B) HEK293T cells were transformed with a plasmid expressing a short-lived YFP under the control of the CMV promoter and cultured for 18 hr. Iron was added to
the cells, and cell samples were taken to assay cellular ferritin by ELISA GFP, tubulin by western blot analysis, and YFP mRNA by RT-PCR. The upper graph
represents changes in 50 IRE-YFP and cellular ferritin over time with the amount of IRE-YFP normalized to tubulin at each time point (Arbitrary Units). 50 IRE-
YFP mRNA was expressed as % YFP mRNA seen, with 100% representing the amount of mRNA seen after 18 hr transfection.
(C) In low-iron conditions, IRP-1/2 is bound to the 50 IRE of ferritin mRNA. Under high-iron conditions, IRP-1/2 is released from the IRE, IRP-1 is populated with an
Fe-S cluster, IRP2 is degraded, and ferritin mRNA is translated. As iron is reduced in the cytosol, ferritin is still translated, but iron levels remain low, and ferritin is
secreted through the secretory apparatus prior to the resynthesis of IRP-2. Error bars represent the standard error of themean of three independent experiments.
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1-15aa-L-ferritin-GFP in cells resulted in a protein that accumu-
lated only in the medium and not the cytosol. These results
suggest that a component of L-ferritin between aa 15 and 25
limits access into the ER. Removal of the first 15 aa of L-ferritin
resulted in retention of truncated L-ferritin-GFP in the cytosol.
We interpret these results tomean that the information for target-
ing of ferritin chains to the ER resides in the amino terminus of
ferritin.
Abrupt Depletion of Cytosolic Iron Induces Ferritin
Secretion, and Ferritin Synthesis Lowers Free
Cytosolic Iron
The finding that ferritin secretion results from decreased cyto-
solic iron is counterintuitive, as iron is required to induce ferritin
synthesis by relieving the translational repression of the IRP
(Rouault, 2006). We hypothesize that the uncoupling of ferritin
synthesis from cytosolic iron is a result of iron sequestration in
ferritin, which decreases free cytosolic iron. The continued
synthesis of ferritin reflects the loss of IRP-binding activity, due
to the degradation of IRP-2 and the presence of Fe-S clusters
RE
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be sequestered in ferritin, will lead to ferritin chain synthesis
and low free cytosolic iron. Secretion of nascent chains would
preclude ferritin assembly and excessive iron sequestration.
We developed an experiment to test this hypothesis. C57BL/6
fibroblasts were incubated with FAC for 18 hr to induce ferritin
accumulation, and then the iron-containing medium was
removed. After incubation in iron-free medium, the permeable
iron chelator desferasirox was added and the incubation
continued. At the time of removal of FAC, there was a large accu-
mulation of ferritin within cells and little ferritin in the medium
(Figure 7A). Upon addition of the iron chelator, there was a
decrease in intracellular ferritin, consistent with degradation of
ferritin by the proteasome (De Domenico et al., 2009). At the
same time, however, there was a transient but dramatic increase
in the amount of ferritin in the medium. This result is consistent
with increased ferritin secretion resulting from decreased cyto-
solic free iron in the absence of RNA-binding IRPs.
In the face of a constant rate of iron uptake, induction of ferritin
synthesis and nanocage assembly should lead to a decrease in
cytosolic iron that triggers ferritin secretion. At some point ironell Metabolism 13, 57–67, January 5, 2011 ª2011 Elsevier Inc. 63
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ferritin synthesis and assembly, iron sequestration, and then
a reduction in cytosolic iron levels. We tested whether there
were periodic changes in cytosolic free iron concentrations
through the use of a 50 IRE-YFP construct in which the YFP con-
tained a mutation that led to a short half-life (Li et al., 2004).
HEK293T cells were transfected with a plasmid expressing 50
IRE-YFP under the control of a CMV promoter. Iron was then
added to cells after 18 hr of transfection; the amount of YFP
was determined by western analysis, the amount of cellular
ferritin by ELISA, and the level of YFP mRNA by RT-PCR (Fig-
ure 7B). Following the addition of iron, there was an increase in
YFP protein levels and an increase in ferritin synthesis, as
expected from the release of IRP. With time, however, there
was a decrease in YFP followed by an increase. While there
were changes in YFP levels, the level of YFP mRNA remained
constant. This result suggests that changes in YFP level
occurred posttranslationally. Of interest is that the accumulation
curve for ferritin shows a break in the slope that occurs at the
same time that YFP levels decrease, as shown in Figure S2;
following the addition of iron, there is a lag of 4 hr prior to the
secretion of ferritin. These results are consistent with the view
that induction of ferritin synthesis can lead to periodic changes
in the concentration of free cytosolic iron.
DISCUSSION
The origin and function of serum ferritin has been a mystery.
There are three conditions that lead to high levels of ferritin
secretion: inflammation, iron overload disease, and mutations
in the IRE of ferritin. Our results suggest a common explanation
for the appearance of serum ferritin in all three conditions, that
ferritin chains gain access to the secretory apparatus under
conditions of low free cytosolic iron. Ferritin chain secretion in
inflammation and iron overload disorders can be explained by
the same reasoning. A wide variety of inflammatory stimuli give
rise to increased hepcidin in plasma (Lee and Beutler, 2009).
Circulating hepcidin binds to the cell-surface iron exporter Fpn,
resulting in its internalization and degradation (Nemeth et al.,
2004). Thus, inflammation results in iron accumulation in macro-
phages, which are continually recycling iron from aged or
damaged red blood cells. Most genetic forms of iron overload
disease result from malregulation of iron absorption due to
decreased plasma hepcidin. Low serum hepcidin levels lead to
increased iron export out of macrophages and enterocytes,
leading to iron accumulation in hepatocytes and other paren-
chymal cells (Pietrangelo and Trautwein, 2004). Our data indi-
cate that all cell types, not justmacrophages, can secrete ferritin.
Increased cytosolic iron leads to ferritin synthesis, resulting in
nanocage accumulation and increased iron sequestration. A
single ferritin nanocage (24 subunits of ferritin) is capable of
accumulating up to 4500 atoms of iron (Theil, 1990). Given
a constant rate of iron entry into cells, at some point assembly
of ferritin into nanocages will result in sequestration of free cyto-
solic iron. It is expected that decreased cytosolic iron would lead
to decreased ferritin translation due to the binding of IRP to the
IRE in ferritin mRNA. For IRP-2, however, this requires new
protein synthesis, as IRP-2 is degraded under high-iron condi-
tions (Salahudeen et al., 2009; Vashisht et al., 2009). Under
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apoprotein into a cytosolic aconitase (Walden et al., 2006). It is
unclear if the aconitase form of IRP-1 can lose its iron and rebind
to an IRE or whether new IRP-1 synthesis is required. We
hypothesize that there is a delay between the decrease in free
cytosolic iron due to sequestration of iron in ferritin nanocages
and resynthesis of IRE-binding forms of IRP-1/IRP-2. Support
for a delay in the reacquisition of RNA-binding activity of IRP
can be found in a study by Chen et al., in which iron-deficient
rats placed on a high-iron diet take hours to increase RNA-
binding activity of IRP-1 and IRP-2 (Chen et al., 1998). In the
absence of IRP inhibition of ferritin translation, decreased free
cytosolic iron, by promoting ferritin chain secretion, would
protect cells from excessive iron sequestration by preventing
the formation of ferritin nanocages (Figure 7C). This model for
ferritin chain secretion also explains serum ferritin in the genetic
disorders of hyperferritinemia.Mutations in the IRE lead to ferritin
chain synthesis under conditions of ambient cytosolic iron. The
steady-state free iron concentration is low enough that ferritin
chains are not assembled, which promotes their secretion.
Secretion of ferritin in hyperferritinemia is also the result of ferritin
synthesis being uncoupled from cytosolic iron levels. Our theory
positing secretion of ferritin resulting from the uncoupling of
ferritin synthesis with cytosolic iron provides an explanation for
the high levels of serum ferritin seen in mice with a targeted dele-
tion of hepatocyte IRP1 and IRP2. Hepatocytes have cytosolic
iron deficiency and high levels of serum ferritin. While increased
serum ferritin may result from hepatic cell damage, at the stage
when measured there was only a 2-fold increase in hepatic
enzymes in serum in the face of a several-hundred-fold increase
in serum ferritin (Galy et al., 2010). Our data suggest that secre-
tion of ferritin chains provides a mechanism to protect cells from
excessive iron sequestration. Secretion of H-ferritin chains by
lens cells was described as a protective mechanism (Goralska
et al., 2003). This protective mechanism would apply to all cells
that synthesize ferritin. We hypothesize that this process is
cyclic. An iron-loaded cell will show periodicity in ferritin secre-
tion, as ferritin secretion will be high when free cytosolic iron
and RNA-binding activity is low, but secretion will be low when
either RNA-binding activity is high or cytosolic iron is high.
The evidence supporting the involvement of the classical
secretory pathway in ferritin secretion is based on the inhibition
of ferritin secretion in response to BFA, silencing Mon1a and
the effects of temperature-sensitive yeast mutants. The electro-
phoretic mobility of mouse serum ferritin is the same as cytosolic
ferritin, suggesting that serum ferritin does not have N-linked
carbohydrates even though mouse H- and L-ferritin chains
each have at least one consensus N-glycosylation site. Human
H- or L-ferritin inserted into canine pancreatic microsomes
in vitro had the same mass as H- and L-ferritin chains made in
the absence of microsomes, suggesting that they do not contain
N-linked carbohydrates. Most studies that discuss glycosylation
of serum ferritin do not directly measure N-glycosylation but
rather measure ConA-binding activity (Worwood et al., 1979).
Those studies and the few studies that do measure endoglyco-
sidase activity (Ghosh et al., 2004) report widely varying degrees
of glycosylation of serum ferritin, ranging from only a small
percent of serum ferritin being glycosylated (Lambotte et al.,
2003) to a significant fraction being glycosylated (Kannengiesser
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determinewhether a ferritinmolecule is glycosylated are unclear.
Previous studies did not detect ferritin chain insertion into the ER
using polyribosomes isolated from liver cells (Tacchini et al.,
1992). We suggest that the high concentration of iron present
in the phosphate-containing buffers employed in polyribosome
isolation may bind to ferritin and prevent ER insertion. As shown
here, iron induces ferritin assembly, and the concentration of iron
determines whether ferritin chains are secreted or assembled.
Secretion is the default pathway, as ferritin chains are secreted
when the concentration of cytosolic iron is below the concentra-
tion required for iron-induced assembly of ferritin nanocages.
This result implies that ferritin monomers can bind iron, and
iron binding induces ferritin nanocage formation. Studies have
identified iron-binding sites on both L- and H-ferritin chains
(Levi et al., 1994; Liu and Theil, 2005; Trikha et al., 1995) that
may be candidates for determining nanocage formation. The
observation that ferritin chains are secreted from cells without
any obvious change in cellular phenotype, such as seen in hyper-
ferritinemia, suggests that the steady-state concentration of
cytosolic iron, estimated at 0.3 and 0.5 mM, is too low to induce
nanocage formation.
Serum ferritin is usually found assembled in nanocages and
contains some iron (ten Kate et al., 1997). Our studies show
that ferritin monomers are inserted into the ER, leading to the
question of how ferritin chains are assembled. We hypothesize
that ferritin chains, once inserted into the ER, can assemble
into nanocages and that iron required for this assembly is trans-
ported into the ER. The concentration of iron that precludes
ferritin assembly in cytosol still permits cellular functions, as cells
are dividing normally. We speculate that iron transporters
present in the ER and/or Golgi provide the iron necessary for
ferritin assembly in the secretory pathway. Evidence for the pres-
ence of ER/Golgi iron transporters comes from studies in insects
in which there are genes that encode ferritin chains that have
a well-defined leader sequence and the ferritin chains are
secreted (Geiser et al., 2006). Assembled iron-containing ferritin
can be visualized within the secretory apparatus of Drosophila
cells (Missirlis et al., 2007). The ER of vertebrate cells contains
resident iron-containing enzymes such as prolyl hydroxylase
(Kivirikko et al., 1989) and lysyl hydroxylase (Suokas et al.,
2003). Expression of prolyl hydroxylases in yeast, an organism
that does not contain prolyl hydroxylase genes, leads to an
active enzyme, indicating that the ability to transport iron into
the secretory apparatus is conserved throughout evolution
(Toman et al., 2000). If mammalian ferritin chains are imported
into the ER as monomers and assembled in the ER, then it is
likely that secreted ferritin obtains its iron in the secretory
apparatus.
Serum ferritin levels are used clinically to assess iron burden in
genetic and transfusion iron overload diseases. These disorders
are relatively rare and are not expected to be a significant
factor in evolution. We think it is more likely that the prime phys-
iological condition that leads to serum ferritin is inflammation.
Most notably, inflammation results in increased hepcidin, which
by downregulating Fpn results in increased iron within macro-
phages and increased ferritin secretion. We hypothesize that in
addition to protecting cells from ferritin-mediated iron seques-
tration, serum ferritin may play a role in signaling or modulating
RE
TRCinflammation (Recalcati et al., 2008). Studies showing the
binding of serum ferritin to lymphocytes (Chen et al., 2005) and
modulation of angiogenesis (Coffman et al., 2009) support that
hypothesis.
EXPERIMENTAL PROCEDURES
Cells and Media
Mouse bone marrow macrophages, isolated from C3H and ffe/+ mouse
femurs, were grown in RPMI 1640 with 20% equine serum for 6 days, and
adherent cells were further cultured in RPMI 1640 with 20% fetal bovine serum
and 30% L cell-conditioned medium. HEK293T cells were maintained in
DMEM with 10% fetal bovine serum. HEK293T Fpn, a stable cell line in which
Fpn-GFP expression is regulated by the ecdysone promoter, has been
described previously (Nemeth et al., 2004). Cells were iron loaded by addition
of FAC (10 mM iron). The Saccharomyces cerevisiae strains used in this study
were a generous gift from R. Schekman (University of California, Berkeley).
Wild-type and sec61-2 strains were transformed with pGAL and pGAL-H+
L-ferritin vectors. Cells were grown in yeast nitrogen base synthetic medium
(CM) with supplements as needed.
Generation of Ferritin Constructs
Human H- and L-ferritin codon sequences lacking in 50 IRE were cloned in
pEGFP-C1 (Clontech; Mountain View, CA), pCMVTag4 (Stratagene, Agilent
Technologies; Santa Clara, CA), and TA vector (Invitrogen), amplified in
Escherichia coli, and sequence-verified before transfecting into mammalian
cells.
Transient Transfection
All ferritin constructs (wild-type or mutant) and pEGFP-50 IRE and pEYFP-50
IRE, kindly provided by J. Barasch (Columbia University), were transfected
using Nucleofector technology (Amaxa; Walkersville, MD), according to the
manufacturer’s instructions.
Ferritin Measurements
Cells were incubated with FAC (10 mM Fe) for the specified times. Cells were
solubilized in 1.0% Triton X-100, 150 mM NaCl, 10 mM EDTA, and 10 mM
Tris (pH 7.4) with a protease inhibitor cocktail (Roche; Boulder, CO). Ferritin
levels were determined by ELISA (Laguna Scientific; Laguna Niguel, CA)
according to the manufacturer’s instructions. Protein concentrations were
determined by bicinchoninic acid assay (Pierce; Rockford, IL). Ferritin levels
from yeast extracts were determined by ELISA as described (Erhardt et al.,
2004) using rabbit anti-ferritin antibody at 0.05 mg/well.
siRNA Transfection
siRNA oligonucleotide pools, nonspecific and mouse Mon1a specific, were
obtained from Dharmacon (Lafayette, CO). Bone marrow macrophages were
transfected using Oligofectamine reagent (Invitrogen) with siRNAs at a final
concentration of 100 nM. Eighteen hours posttransfection, cells were trypsi-
nized and plated onto 60 mm plates. Cells were grown for 18–24 hr and incu-
bated with FAC for 18 hr before determining ferritin levels.
In Vitro Transcription and Translation Assay
The codon sequence of ferritin minus the 50 IRE was transcribed in vitro using
MAXIscript T7/T3 Kit (Ambion; Austin, TX) according to the manufacturer’s
instructions. Translation reactions were performed as previously described
(Tacchini et al., 1992) in the presence or absence of metals at the defined
concentration.
Other Procedures
Cells were incubated with 100 mM desferasirox, a generous gift from Prem
Ponka (McGill University). Cells were solubilized in 1.0% Triton X-100,
150 mM NaCl, 10 mM EDTA, and 10 mM Tris (pH 7.4) with a protease inhibitor
cocktail (Roche). Ferritin was immunoprecipitated using mouse anti-ferritin
(1:500, Sigma-Aldrich), rabbit anti-L-ferritin (1:250, a gift from Paulo Arosio),
or rabbit anti-H-ferritin (1:250, a gift from Paulo Arosio) and protein A/G
agarose (Santa Cruz) at 4C overnight. Protein samples were separated on
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Ferritin Secretion12% SDS-PAGE and transferred to Hybond ECL nitrocellulose (GE Health-
care). Western analysis was performed using mouse anti-ferritin (1:1000,
Sigma-Aldrich), mouse anti-tubulin (1:1000, Gene Tex), rabbit anti-GFP
(1:10,000, Abcam), rabbit anti-Mon1a (1:1000), rabbit anti-H-ferritin (1:1000),
rabbit anti-L-ferritin (1:1000), or goat anti-Cp (1:5000, Abcam) followed by
treatment with peroxidase-conjugated goat anti-mouse IgG (1:10,000, Jack-
son Laboratory), peroxidase-conjugated goat anti-rabbit IgG (1:10,000, Jack-
son Laboratory), or peroxidase-conjugated donkey anti-goat IgG (1:5000,
Santa Cruz). Cells expressing ferritin-GFP were visualized using an epifluores-
cence microscope (Olympus Inc.) with a X100 oil immersion objective. Images
were acquired using Pictureframer software (Olympus Inc.).
Statistics
Experiments were performed a minimum of three times, and the error bars,
calculated using Student’s t test, represent the standard error of the mean.
SUPPLEMENTAL INFORMATION
Supplemental Information includes four figures and can be found with this
article online at doi:10.1016/j.cmet.2010.12.003.
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